Cargando…
1416. Piperacillin/Tazobactam Therapeutic Drug Monitoring: True Interpatient Variability or Compound Instability?
BACKGROUND: β-Lactam exposure is frequently documented to be inadequate in critically ill patients implying that therapeutic drug monitoring (TDM) may be necessary to optimize efficacy. Practical barriers to implementation of TDM for β-lactam/β-lactamase inhibitor combinations include potential chem...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254500/ http://dx.doi.org/10.1093/ofid/ofy210.1247 |